In-Silico Drug Discovery Market Report: Trends, Forecast and Competitive Analysis to 2030

In-Silico Drug Discovery Trends and Forecast

The future of the global in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets. The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030 with a CAGR of 10.2% from 2024 to 2030. The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.

A more than 150-page report is developed to help in your business decisions. Sample figures with some insights are shown below.

In-Silico Drug Discovery by Segment

The study includes a forecast for the global in-silico drug discovery by type, target therapeutic area, workflow, end use, and region.

In-Silico Drug Discovery Market by Type [Shipment Analysis by Value from 2018 to 2030]:

• Software as a Service
• Consultancy as a Service
• Software

In-Silico Drug Discovery Market by Target Therapeutic Area [Shipment Analysis by Value from 2018 to 2030]:

• Human Immunodeficiency Virus (HIV)
• Infectious Diseases
• Metabolic Disorders
• Mental Disorders
• Musculoskeletal Disorders
• Neurological Disorders
• Oncological Disorders
• Respiratory Disorders
• Others

In-Silico Drug Discovery Market by Workflow [Shipment Analysis by Value from 2018 to 2030]:

• Discovery
• Target Identification
• Reverse Docking
• Bioinformatics
• Protein Structure Prediction
• Target Validation
• Lead Discovery
• Pharmacophore
• Others

In-Silico Drug Discovery Market by End Use [Shipment Analysis by Value from 2018 to 2030]:

• Contract Research Organizations
• Pharmaceutical Industry
• Academic & Research Institutes
• Others

In-Silico Drug Discovery Market by Region [Shipment Analysis by Value from 2018 to 2030]:

• North America
• Europe
• Asia Pacific
• The Rest of the World

List of In-Silico Drug Discovery Companies

Companies in the market compete on the basis of product quality offered. Major players in this market focus on expanding their manufacturing facilities, R&D investments, infrastructural development, and leverage integration opportunities across the value chain. With these strategies in-silico drug discovery companies cater increasing demand, ensure competitive effectiveness, develop innovative products & technologies, reduce production costs, and expand their customer base. Some of the in-silico drug discovery companies profiled in this report include-

• Curia
• Certara
• Charles River Laboratories
• Chemical Computing
• GenScript
• Sygnature Discovery
• Abzena

In-Silico Drug Discovery Market Insights

The publisher forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.
Within this market, pharmaceutical industry will remain the largest segment due as in-silico drug discovery helps the pharmaceutical companies to reduce the time and cost of developing new drugs.
North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.

Features of the Global In-Silico Drug Discovery Market

• Market Size Estimates: In-silico drug discovery market size estimation in terms of value ($B).
• Trend and Forecast Analysis: Market trends (2018 to 2023) and forecast (2024 to 2030) by various segments and regions.
• Segmentation Analysis: In-silico drug discovery market size by various segments, such as by type, target therapeutic area, workflow, end use, and region in terms of value ($B).
• Regional Analysis: In-silico drug discovery market breakdown by North America, Europe, Asia Pacific, and Rest of the World.
• Growth Opportunities: Analysis of growth opportunities in different types, target therapeutic areas, workflow, end uses, and regions for the in-silico drug discovery market.
• Strategic Analysis: This includes M&A, new product development, and competitive landscape of the in-silico drug discovery market.
• Analysis of competitive intensity of the industry based on Porter’s Five Forces model.

FAQ

Q1. What is the in-silico drug discovery market size?
Answer: The global in-silico drug discovery market is expected to reach an estimated $5.45 billion by 2030.

Q2. What is the growth forecast for in-silico drug discovery market?
Answer: The global in-silico drug discovery market is expected to grow with a CAGR of 10.2% from 2024 to 2030.

Q3. What are the major drivers influencing the growth of the in-silico drug discovery market?
Answer: The major drivers for this market are rising focus towards reduction of medication errors, increasing adoption of cloud-based applications in drug discovery, and on-going advancements in computational biology.

Q4. What are the major segments for in-silico drug discovery market?
Answer: The future of the in-silico drug discovery market looks promising with opportunities in the contract research organizations, pharmaceutical industry, and academic & research institutes markets.

Q5. Who are the key in-silico drug discovery market companies?

Answer: Some of the key in-silico drug discovery companies are as follows:

• Curia
• Certara
• Charles River Laboratories
• Chemical Computing
• GenScript
• Sygnature Discovery
• Abzena

Q6. Which in-silico drug discovery market segment will be the largest in future?
Answer: The publisher forecasts that software as a service is expected to witness the highest growth over the forecast period due to its increasing adoption for virtual screening and target fising in the drug discovery procedure.

Q7. In in-silico drug discovery market, which region is expected to be the largest in next 5 years?
Answer: North America will remain the largest region over the forecast period due to increasing R&D expenditure by biopharma company, strong presence of marlet players, and large patient population suffering from various chronic and infectious diseases in the region.

Q.8 Do we receive customization in this report?
Answer: Yes, the publisher provides 10% customization without any additional cost.

This report answers following 11 key questions:

Q.1. What are some of the most promising, high-growth opportunities for the in-silico drug discovery market by type (software as a service, consultancy as a service, and software), target therapeutic area (human immunodeficiency virus (HIV), infectious diseases, metabolic disorders, mental disorders, musculoskeletal disorders, neurological disorders, oncological disorders, respiratory disorders, and others), workflow (discovery, target identification, reverse docking, bioinformatics, protein structure prediction, target validation, lead discovery, pharmacophore, and others), end use (contract research organizations, pharmaceutical industry, academic & research institutes, and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?
Q.2. Which segments will grow at a faster pace and why?
Q.3. Which region will grow at a faster pace and why?
Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?
Q.5. What are the business risks and competitive threats in this market?
Q.6. What are the emerging trends in this market and the reasons behind them?
Q.7. What are some of the changing demands of customers in the market?
Q.8. What are the new developments in the market? Which companies are leading these developments?
Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?
Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or product substitution?
Q.11. What M&A activity has occurred in the last 5 years and what has its impact been on the industry?


This product will be delivered within 1-3 business days.